Cavco Industries, Inc. CVCO
1 trading plan running, 9 Form 144 notices for $4.5M
10-Q, 10-K and Form 144What CVCO's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Aug 9, 2024 to Jan 31, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired.
| Insider | What | Date | Reported in | ||
|---|---|---|---|---|---|
| Seth Schuknecht Executive Vice President and General Counsel |
Adopted 10b5-1 plan | Feb 25, 2026 | 10-K May 22, 2026 | ||
What the company wroteOn February 25, 2026, Seth Schuknecht, the Company's Executive Vice President and General Counsel, adopted a programmed plan of transactions intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) (the "Schuknecht 10b5-1 Plan"). This plan provides for a first possible trade date of May 27, 2026, and terminates automatically on January 31, 2027, if not before. The aggregate number of shares to potentially be sold pursuant to the Schuknecht 10b5-1 Plan is up to 542 shares of Common Stock. | |||||
| Lisa Daniels independent director |
Adopted 10b5-1 plan | Dec 12, 2025 | 10-Q Feb 2, 2026 | ||
What the company wroteOn December 12, 2025, Lisa Daniels, an independent director, also adopted a programmed plan of transactions intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) (the "Daniels 10b5-1 Plan"). This plan was adopted in order to sell-to-cover a number of shares of our Common Stock to satisfy income tax obligations to be incurred by Ms. Daniels in connection with the anticipated vesting of her restricted stock units on July 28, 2026. The Daniels 10b5-1 Plan provides for a first possible trade date of July 30, 2026, and terminates automatically on August 5, 2026. The aggregate number of shares to be sold pursuant to the plan is 30 shares of our Common Stock. | |||||
| Allison Aden Chief Financial Officer |
Adopted 10b5-1 plan | Nov 26, 2025 | 10-Q Feb 2, 2026 | ||
What the company wroteOn November 26, 2025, Allison Aden, the Company's Chief Financial Officer, adopted a programmed plan of transactions intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) (the "Aden 10b5-1 Plan"). This plan provides for a first possible trade date of February 25, 2026, and terminates automatically on July 3, 2026, if not before. The aggregate number of shares to potentially be sold pursuant to the Aden 10b5-1 Plan is up to 3,000 shares of Common Stock. | |||||
| David Greenblatt director |
Ended 10b5-1 plan | Mar 5, 2025 | 10-K May 23, 2025 | ||
What the company wroteOn March 5, 2025, David Greenblatt, a director, terminated his previously adopted plan of transactions intended to satisfy the affirmative defense provided by Rule 10b5-1(c). This plan was entered into on December 4, 2024, was set to end on April 15, 2025, and provided for the sale of 4,000 shares of our common stock. | |||||
| Susan Blount director |
Ended 10b5-1 plan | Jan 15, 2025 | 10-K May 23, 2025 | ||
What the company wroteOn January 15, 2025, Susan Blount, a director, terminated her previously adopted plan of transactions intended to satisfy the affirmative defense provided by Rule 10b5-1(c). This plan was entered into on September 13, 2024, was set to end on January 30, 2025, and provided for the sale of 1,500 shares of our common stock. | |||||
| Julia Sze director |
Ended 10b5-1 plan | Dec 10, 2024 | 10-Q Jan 31, 2025 | ||
What the company wroteOn December 10, 2024, Julia Sze, a director, terminated her previously adopted plan of transactions intended to satisfy the affirmative defense provided by Rule 10b5-1(c). This plan was entered into on August 9, 2024, was set to end on December 10, 2024, and provided for the sale of 250 shares of our Common Stock. | |||||
| David Greenblatt director |
Adopted 10b5-1 plan | Dec 4, 2024 | 10-Q Jan 31, 2025 | ||
What the company wroteOn December 4, 2024, David Greenblatt, a director, adopted a programmed plan of transactions intended to satisfy the affirmative defense provided by Rule 10b5-1(c) (the "Greenblatt 10b5-1 Plan"). This plan provides for a first possible trade date of March 5, 2025, and terminates automatically on April 15, 2025, if not before. The aggregate number of shares to potentially be sold pursuant to the Greenblatt 10b5-1 Plan is up to 4,000 shares of Common Stock. | |||||
| Susan Blount independent director |
Adopted 10b5-1 plan | Sep 13, 2024 | 10-Q Nov 1, 2024 | ||
What the company wroteOn September 13, 2024, Susan Blount, an independent director, also adopted a programmed plan of transactions intended to satisfy the affirmative defense provided by Rule 10b5-1 (the "Blount 10b5-1 Plan"). This plan provides for a first possible trade date of December 13, 2024, and terminates automatically on January 30, 2025. The aggregate number of shares to be sold pursuant to the Blount 10b5-1 Plan is 1,500 shares of Common Stock. | |||||
| Julia Sze independent director |
Adopted 10b5-1 plan | Aug 9, 2024 | 10-Q Nov 1, 2024 | ||
What the company wroteOn August 9, 2024, Julia Sze, an independent director, adopted a programmed plan of transactions intended to satisfy the affirmative defense provided by Rule 10b5-1 (the "Sze 10b5-1 Plan"). This plan was adopted in order to sell-to-cover a number of shares of our Common Stock to satisfy tax withholding obligations in connection with the vesting of Ms. Sze's restricted stock units on July 30, 2024. The Sze 10b5-1 Plan provides for a first possible trade date of November 8, 2024, and terminates automatically on December 10, 2024. The aggregate number of shares to be sold pursuant to the plan is 250 shares of our Common Stock. | |||||
| Seth Schuknecht Executive Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary |
Adopted 10b5-1 plan | – | 10-Q Jan 31, 2025 | ||
What the company wroteOn December 5, 2024, Seth Schuknecht, Executive Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary also adopted a programmed plan of transactions intended to satisfy the affirmative defense provided by Rule 10b5-1(c) (the "Schuknecht 10b5-1 Plan"). This plan provides for a first possible trade date of March 6, 2025, and terminates automatically on October 31, 2025, if not before. The aggregate number of shares to potentially be sold pursuant to the Schuknecht 10b5-1 Plan is up to 167 shares of Common Stock. | |||||
Show the other 2 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 19, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Nov 10, 2026 | BRIAN CIRA Officer |
2,382 | $1.6M |
| Nov 4, 2026 | SETH G SCHUKNECHT Officer |
542 | $351K |
| Nov 4, 2026 | KERLEY RICHARD A Director |
459 | $298K |
| Aug 17, 2026 | BIGBEE PAUL Officer |
342 | $208K |
| Jul 30, 2026 | LISA DANIELS Director |
30 | $17K |
| Jun 25, 2026 | ALLISON ADEN Officer |
1,473 | $901K |
| Jun 15, 2026 | BIGBEE PAUL Officer |
200 | $108K |
| Jun 12, 2026 | ALLISON K. ADEN Officer |
1,208 | $724K |
| Jun 8, 2026 | KERLEY RICHARD A Director |
500 | $281K |
Show the other 1 notices
From the Form 144 XML filed with the SEC, since Jun 8, 2026. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CVCO/export.csv") into a cell.